RET and adenocarcinoma: Although statistical comparisons were not made, there were notable numerical differences between the overall aNSCLC cohort and the RET fusion-positive cohort for some parameters, including higher proportions of White/Caucasian patients (68% vs. 84%), never smokers (23% vs. 36%), and histology of adenocarcinoma (70% vs. 88%), and lower proportion of squamous cell carcinoma (25% vs. 6%), in the RET fusion-positive cohort.